820 results found
The Australian Government commissioned a review of the clinical effectiveness of 16 natural therapies excluded from private health insurance rebates in April 2019. The Department of Health and Aged Care engaged National Health and Medical Research Council (NHMRC) to assist in its review by commissioning evidence evaluations that assessed published scientific research on the excluded therapies. NHMRC completed its role in the Natural Therapies Review 2024 with submission of all finalised evidence evaluations to the Department of Health and Aged Care in January 2025.
National Reconciliation Week is a time for all Australians to learn about our shared histories, cultures, and achievements, and to explore how each of us can join the national efforts towards achieving national reconciliation.In this Speaking of Science webinar held during National Reconciliation Week (27 May – 3 June 2024), we were joined by distinguished researcher and Indigenous leader, Professor Maree Toombs (Professor of Aboriginal and Torres Strait Islander Health in the University of New South Wales School of Population Health) who walked us through an incredibly moving presentation.
Members of the Council of National Health and Medical Research Council (NHMRC), 2024–2027 triennium.
CEO Communique – February 2022
Linked to Road Map 3: A Strategic Framework for Improving Aboriginal and Torres Strait Islander Health through Research (Road Map 3)
NHMRC is committed to building and strengthening the capacity and capability amongst Aboriginal and Torres Strait Islander health researchers. We do this through funding, events and educational opportunities. Read about some of the capacity and capability initiatives we are involved with.
The Embryo Research Licensing Committee (ERLC) maintains an online database of general and mitochondrial donation licences.
NHMRC recognises excellence in the health and medical research sector through its annual Research Excellence Awards. Find our 2023 award winners listed below.
The 46th biannual report
The 45th biannual report
Around 1,786 new cases of ovarian cancer in Australia were estimated to have been diagnosed in 2023, which is the equivalent of a 1 in 87 lifetime risk.In our first Speaking of Science webinar, held for Ovarian Cancer Awareness Month, we were joined by international expert in ovarian cancer research, Professor Susan Ramus (Professor of Molecular Oncology in the School of Clinical Medicine at the University of New South Wales).
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2024–25.An accessible version of this document is available on the Transparency Portal.
The NHMRC Corporate Plan 2025–26 presents our strategy for building a healthy Australia, across the strategic themes (purposes) of investment, translation and integrity of health and medical research. The plan also includes our strategic and health priorities, as well as our key activities planned for 2025–26 and over the next few years. The plan describes the operating context in which we work and outlines our performance criteria and targets for the next 4 years.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2020–21. An accessible version of this document is available on the Transparency Portal.